We improve the quality of life
By discovering and developing innovative biological MSC stem cells therapies and make them accessible to patients throughout the world.
By keeping our patients’ and customers’ safety and well-being at the core of everything we do.
By partnering with leading hospitals, healthcare professionals and academia.
Our business in numbers
ASCs from 100 ml of adipose tissue over 2 weeks 3D cell culturing
Patent coverage of global market until 2034
More volume (fat retention) compared to conventional fat grafting published in The Lancet
Real World Patients treated
Our core science is focused on producing and expanding very high quantities of potent autologous MSCs. Despite the many opportunities in cell therapy, the focus of StemMedical is clear and divided into two main strategic segments.
focuses on using the technology for hard-to-treat inflammatory conditions with initial focus on musculoskeletal disorders.
covers the cosmetic application of the technology. Stemform cultured stem cell fat transfer treatment offers women a natural and effective breast augmentation as an alternative to artificial implants.
StemMedical is a versatile mesenchymal stem cell therapy platform with broad applicability
Startup hyrede ham efter 18 år i Novo Nordisk: Nu vil han skabe raketvækst på fedt til bryster.
Stem Medical vil erstatte brystimplantater med en stamcellebaseret løsning – nye investorer skal sikre europæisk udrulning.
LSX World Congress 2023
Leading investors discuss the global investment landscape and shifts in public and private finance, as well as what they expect 2023 and onwards to hold.